PTEN Research institute

PTEN Research Institute

Pier Paolo Pandolfi is actively involved with the PTEN Research Institute (PRI), an educational and research-driven organization committed to advancing the future of cancer care. PRI focuses on pioneering targeted therapies for PTEN Hamartoma Tumor Syndromes (PHTS) and related genetic cancer susceptibility conditions. Through cutting-edge research and collaboration, the institute works to transform cancer prevention, treatment, and the pursuit of a cure. Discover more about their mission and impact at www.ptenresearchinstitute.org